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Cod (Gadus morhua L.)
Ontogeny
A B S T R A C T
Pentraxins are fluid phase pattern recognition molecules that form an important part of the innate immune
defence and are conserved between fish and human. In Atlantic cod (Gadus morhua L.), two pentraxin-like
proteins have been described, CRP-I and CRP-II. Here we show for the first time that these two CRP forms are
post-translationally deiminated (an irreversible conversion of arginine to citrulline) and differ with respect to
tissue specific localisation in cod ontogeny from 3 to 84 days post hatching. While both forms are expressed in
liver, albeit at temporally differing levels, CRP-I shows a strong association with nervous tissue while CRP-II is
strongly associated to mucosal tissues of gut and skin. This indicates differing roles for the two pentraxin types in
immune responses and tissue remodelling, also elucidating novel roles for CRP-I in the nervous system. The
presence of deimination positive bands for cod CRPs varied somewhat between mucus and serum, possibly
facilitating CRP protein moonlighting, allowing the same protein to exhibit a range of biological functions and
thus meeting different functional requirements in different tissues. The presented findings may further current
understanding of the diverse roles of pentraxins in teleost immune defences and tissue remodelling, as well as in
various human pathologies, including autoimmune diseases, amyloidosis and cancer.
1. Introduction
Pentraxins are ancient pattern recognition molecules that evolved
alongside the complement system and are conserved throughout phy-
logeny from arthropods to mammals. They play important roles in in-
nate immunity, homeostatic regulation and the acute phase response,
which is set off by injury, infection or other trauma and involves the
immune system as well as other biological and physiological processes
(Pepys et al., 1978; Robey and Liu, 1981; Martinez de la Torre et al.,
2010). Pentraxins have been classified into four groups, two belonging
to the group of long pentraxins (PTX3 and neural pentraxins), while C-
reactive protein (CRP) and serum amyloid protein (SAP) are the short
pentraxins and protypical mammalian acute phase proteins of hepatic
origin present in serum (Ballou and Kushner, 1992; Martinez de la Torre
et al., 2010). Human CRP and SAP share 51% amino acid identity and
are believed to be products of a gene duplication event over 500 million
years ago (Shrive et al., 1999; Bayne and Gerwick, 2001).
CRP are pentameric non-covalently associated globular protomers,
with approximately 206 amino acids folded into two anti-parallel beta-
sheets, with each subunit of 23 kDa molecular mass. Each of the five
subunits is linked by disulphide bonds (Shrive et al., 1996; Thiele et al.,
2015). There is some variation in CRP structure as while CRP in zeb-
rafish has been found to form trimers (Chen et al., 2015), cod CRP was
revealed to have a pentameric structure by electron microscopy
(Gisladottir et al., 2009), as does human CRP. CRP binds to phos-
phorylcholine on pathogen surfaces and can also bind to nuclear his-
tones, chromatin and small nuclear ribonucleoproteins (Du Clos, 1996;
Ansar and Ghosh, 2013). CRP activates the complement pathway via
C1q binding and has thus roles both in the clearance of bacteria as well
as of altered and dying cells (Mihlan et al., 2011; Thiele et al., 2015).
While CRP is not pro-inflammatory under physiological conditions, its
hepatic synthesis is increased in response to injury and can aggravate
existing tissue injury in a complement-mediated manner, for example in
myocardial infarction and ischemic cerebral injury (Griselli et al., 1999;
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Gill et al., 2004). CRP also binds to low-density lipoprotein in a Ca2+
dependent manner and is linked to atherosclerosis (Reynolds and
Vance, 1987; Sun et al., 2005). While changes in CRP levels are linked
to various autoimmune diseases and cancer, the effects of structural
changes in CRP are gaining increased interest (Ji et al., 2007;
Eisenhardt et al., 2009; Thiele et al., 2014; Braig et al., 2017; Bello-
Perez et al., 2017a).
SAP is a 25 kDa pentameric glycoprotein and recognises carbohy-
drates, amyloid fibrils and nuclear substances (Xi et al., 2015). While it
is not an acute phase protein in human, it serves as an acute phase
protein in mice, where CRP does not display acute phase protein
function (Cathcart et al., 1965). SAP binds to lipopolysaccharide (LPS)
on various bacteria and can prevent LPS-mediated complement acti-
vation and LPS-toxicity (De Haas et al., 1999; De Haas et al., 2000). SAP
is associated to systemic amyloidosis, Alzheimer's disease and trans-
missible spongiform encephalitis (Pepys et al., 1994), and has been
suggested to serve as a chaperone in amyloidosis by binding to the
pathological amyloid cross-beta-sheet structures (Agrawal et al., 2009).
SAP is also associated to chromatin degradation and can bind to early
apoptotic cells (Gershov et al., 2000; Lu et al., 2012).
In fish, both CRP and SAP-like pentraxins have been detected in
serum and while some species have both types, such as rainbow trout
(Oncorynchus mykiss) (Murata et al., 1994, 1995), dogfish (Mustelus
canis) (Robey et al., 1983) and plaice (Pleuronectes platessa) (White
et al., 1981), others have either CRP or SAP-like pentraxins. For ex-
ample in channel catfish (Ictalurus punctatus), Japanese eel (Anguilla
japonica), murrel (Channa punctatus), carp (Cyprinus carpio) and goldfish
(Carassius auratus), CRP forms are found (Szalai et al., 1994; Nunomura,
1991; Mitra and Bhattacharya, 1992; Cartwright et al., 2004; Kovacevic
et al., 2015), while SAP proteins are found in Arctic char (Salvelinus
alpinus L.), Atlantic salmon (Salmo salar), halibut (Hippoglossus hippo-
glossus L.), wolffish (Anarhichas lupus) and snapper (Pagrus auratus)
(Jensen et al., 1997; Lund and Olafsen, 1998, 1999; Cook et al., 2005;
Lee et al., 2017). These classifications have generally been based on N-
terminal amino acid sequence analysis and calcium-dependent ligand
binding specificity to either phosphorylcholine (for CRP) or phos-
phoethanolamine, agarose, zymosan, glycans, DNA and chromatin (for
SAP) (Tennent and Pepys, 1994). In zebrafish, 7 isoforms of CRP have
been identified and to date zebrafish is the only fish CRP crystallized
and has been shown to form trimers rather than pentamers (Chen et al.,
2011).
Both CRP and SAP are resistant to proteolysis, the resistance to
proteolysis of human CRP is Ca2+ dependent, and human CRP has a
slightly shorter half-life of 19 h compared to 24 h for SAP (Hawkins
et al., 1990; Vigushin et al., 1993; Agrawal et al., 2009). In addition,
pentraxins have been shown in some cases to be under hormonal con-
trol (Coe and Ross, 1990; Szalai et al., 1998). While the glycosylation of
CRP and SAP has been studied, and CRP has for example been shown to
variate in glycosylation patterns and binding characteristics in different
pathological conditions (Das et al., 2004), other post-translational
modifications, including deimination, have not been studied before and
may further understanding of the functional repertoire of CRP and SAP
depending on tissue type and environmental factors. Post-translational
protein deimination is receiving increasing attention in the medical
field due to emerging critical roles in a variety of pathologies, including
autoimmune diseases, central nervous system insult and degeneration,
as well as cancer (Vossenaar et al., 2003; György et al., 2006; Wang and
Wang, 2013; Lange et al., 2014, 2017; Witalison et al., 2015a). Protein
deimination is caused by peptidylarginine deiminases (PADs), a family
of calcium dependent enzymes, which cause irreversible conversion of
protein arginine to citrulline in target proteins in a Ca2+ - dependent
manner, leading to structural and functional changes of target proteins
(Fig. 1; Vossenaar et al., 2003; György et al., 2006; Bicker and
Thompson, 2013). Each conversion of an arginine into a citrulline leads
to a loss in charge and decreased molecular mass of 1 Da. This can affect
protein-protein interactions, protein structure and hydrogen bond
formation, as well as cause denaturation (Tarcsa et al., 1996; Witalison
et al., 2015a). Structures most prone to deimination are beta-sheets and
intrinsically disordered proteins, while the position of the arginine is
also important; arginines sitting next to aspartic acid residues are most
prone to citrullination, arginines next to glutamic acid residues are
rarely citrullinated and those flanked by proline are poorly citrullinated
(Nomura, 1992; Tarcsa et al., 1996; György et al., 2006). PADs are
conserved through phylogeny from bacteria to mammals, and while
five tissue-specific isozymes are present in mammals, only one is pre-
sent in fish (Vossenaar et al., 2003; Rebl et al., 2010). PAD is found in
the cod genome (Star et al., 2011) and was recently verified at the
protein level and shown to have deiminating activity in both cod serum
and mucosa, where 38 deiminated mucosal target proteins were iden-
tified, including nuclear, immune-related, metabolic and cytoskeletal
proteins. In addition, deiminated proteins, including histone H3, were
detected in various organs and mucosal tissues during early cod onto-
geny and in immunostimulated cod larvae (Magnadottir et al., 2018).
The two CRP forms in cod under study here were previously clas-
sified as belonging to the CRP type pentraxins due to their binding
specificity to phosphorylcholine, while N-terminal amino-acid analysis
showed higher similarity for CRP-I to SAP. The two forms were pre-
viously shown to vary in overall charge, glycosylation, pentameric and
subunit molecular size (Gisladottir et al., 2009). In relation to our
previous studies on innate immune factors during cod ontogeny, in-
cluding CRP and complement factors (Magnadottir et al., 2004; Lange
et al., 2004, 2005), we set out to identify whether the two cod CRP
forms differed in tissue specific localisation during early cod ontogeny.
While both pentraxin forms were strongly detected in liver, extra-
hepatic detection of both forms was found. CRP-I was dominant in
nervous tissue of brain and eye, while CRP-II showed strong specificity
to mucosal surfaces of gut and skin throughout early ontogeny. To gain
further understanding of putative functional differences due to post-
translational modifications, that can affect structural changes (Fig. 1)
and facilitate protein moonlighting, an evolutionary acquired phe-
nomenon allowing proteins to exhibit more than one physiologically
relevant biochemical or biophysical function within one polypeptide
chain (Henderson and Martin, 2014; Jeffrey, 2018), we set out to
identify whether the two cod CRP forms were post-translationally dei-
minated. Due to the conserved function of pentraxins throughout
phylogeny, this would be of high importance also for human patholo-
gies as protein deimination has previously not been described for either
CRP or SAP in fish or mammals. We show here for the first time dei-
minated forms of CRP and SAP-like pentraxins, also varying in deimi-
nation between mucus and serum. This highlights novel roles for post-
translational deimination in pentraxin protein moonlighting and may
shed novel light on the differing responses of CRP and SAP in various
associated pathologies, such as autoimmune diseases, amyloidosis and
cancer.
2. Materials and methods
2.1. CRP-I and CRP-II sequence alignment and phylogenetic reconstruction
CRP and SAP sequences were retrieved from Ensembl (http://www.
ensembl.org/index.html) and NCBI (https://www.ncbi.nlm.nih.gov/),
translated to protein and multiple sequence alignment was performed
using the MUSCLE sequence alignment tool (https://www.ebi.ac.uk/
Tools/msa/muscle/). Evolutionary analyses were conducted in MEGA6
(Tamura et al., 2013). Phylogenetic relationships of the pentraxin
proteins were inferred using the Neighbour-Joining method under the
conditions of the Poisson correction distance model and pairwise de-
letion of gaps. Bootstrap analysis with 10,000 replicates was used to
assess nodal support. The analysis involved only full length protein
sequences of short pentraxins (CRP and SAP) from species representing
a range of taxa: teleost represented by zebrafish (Danio rerio CRP
(pentraxin fusion protein) AET80950.1), rainbow trout (Oncorhynchus
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mykiss, CRP NP_001118193.1; SAP XP_021435889.1), common carp
(Cyprinus carpio carpio CRP-like-1: AEU04518.1; CRP-like-2:
AEU04520.1), goldfish (Carassius auratus CRP AKO22072.1), Arctic
char (Salvelinus alpinus L. CRP XP_023864349.1; SAP XP_023862668.1),
Atlantic salmon (Salmo salar SAP CAA67765.1), Northern pike (Esox
Lucius SAP NP_001290956.1); and Atlantic cod (Gadus morhua L. pen-
traxin ACZ06557.1; Seppola et al., 2009, which was similar as CRP-I
P86688.1 isolated by Gisladottir et al., 2009), CRP-II P86689.1 (full
length sequence used from Gisladottir et al. (2009) (Supplementary
Fig. 1); amphibian xenopus (Xenopus laevis CRP NP_001165686.1; SAP
NP_001008175.1); reptilian python (Python bivittatus SAP:
XP_007444909.1) and alligator (Alligator mississippiensis SAP
XP_006272649.1); avian red junglefowl (Gallus gallus, CRP
NP_001034653.1); Syrian hamster (Mesocricetus auratus, CRP
AAB19893.2; SAP P07629.2), mouse (Mus musculus CRP NP_031794.3;
SAP EDL39002.1), rat (Rattus norvegicus SAP EDL94729.1); and man
(Homo sapiens, CRP AAL48218.2; SAP NP_001630). Arthropod horse-
shoe crab (Limulus Polyphemus; CRP AAA28268.1 and SAP AAL55404),
was used as outgroup. CRP and SAP sequences were further analysed
for putative disordered regions using FoldIndex© (Uversky et al., 2000;
Prilusky et al., 2005; https://fold.weizmann.ac.il/fldbin/findex).
2.1.1. Larval sampling
Experimentally farmed cod (Gadus morhua L) larvae were obtained
from the Marine Research Institute Mariculture Laboratory, Stadur,
Grindavik, Iceland; reared as described before (Steinarsson and
Björnsson, 1999; Lange et al., 2004). Cod larvae were collected during
the hatching season from the same hatching batch at 3–5, 7, 14, 21, 28,
35, 50 and 84 days post hatching (d.p.h; for the relationship between
days after hatching and body length in mm see Supplementary Fig. 2).
Four larvae for each date were collected, fixed in 4% formalin in
phosphate buffered saline (PBS) at 4 °C for 24 h, followed by embedding
in paraffin for tissue sectioning and histological analysis.
2.1.2. Mucus sampling and preparation
A pool of cod mucus was carefully collected from the dorsal side of
the body of 10 individual adult fish (2–3 year old; 400–1000 g, reared
at 4–9 °C), gently using a glass slide to avoid contamination with blood
or epithelium cells. The mucus pool was immediately frozen on dry ice
and protein extracted according to Al-Harbi and Austin (1993). In brief,
mucus was homogenized and dialyzed in PBS at 4 °C, protein extracted
from the isolated protein pellet using 50% saturated ammonium sul-
phate for 1 h at room temperature and thereafter dialysed in saline for
48 h at 4 °C. Precipitated protein isolates were quantified by Bradford
assay (Bradford, 1976) and reconstituted in 2 × Laemmli buffer for
Western blotting analysis.
2.2. Immunoprecipitation
Cod pentraxins CRP-I and CRP-II were immunoprecipitated from the
protein extract of cod mucus (2.2.3) and a pool of serum from 5 in-
dividual adult cod respectively. Immunoprecipitation was performed
using the Catch and Release®v2.0 Reversible Immunoprecipitation
System (Merck, U.K.) according to the manufacturer's instructions,
using monospecific polyclonal mouse anti-CRP-I and CRP-II antibodies
previously described (Gisladottir et al., 2009). Bound proteins were
eluted and analysed by Western blotting.
2.3. Western blotting
Immunoprecipitated CRP-I and CRP-II from cod mucus and serum,
as well as crude mucus and serum protein extracts, were heated to
100 °C in 2 × Laemmli buffer containing 5% β-mercaptoethanol before
separation by SDS-PAGE using 4–20% Mini-Protean TGX protein gels
(BioRad, U.K) and thereafter analysed by Western blotting using the
monospecific mouse anti-cod CRP-I and CRP-II antibodies, as well as
the monoclonal F95 mouse IgM antibody, that was raised against a
deca-citrullinated peptide and specifically detects protein citrulline
(Nicholas and Whitaker, 2002), for the detection of putative deimi-
nated/citrullinated sites in CRP-I and CRP-II. The detection of deimi-
nated forms of CRP-I and CRP-II was thus assessed by using the F95
antibody to blot the immunoprecipitated CRP fractions, isolated from
mucus and serum using the monospecific CRP-I and CRP-II antibodies
respectively, as described in 2.3. Approximately 5 μg of protein was
loaded per lane, even load was assessed using Ponceau S staining
(Sigma, U.K.), membranes were thereafter blocked in 5% bovine serum
albumin (BSA) in Tris buffered saline with 0.01% Tween20 (TBS-T) for
1 h, followed by incubation at 4 °C overnight with the primary anti-
bodies (anti-CRP-I and anti-CRP-II 1/1000; F95 1/5000). Membranes
were then washed three times in TBS-T, incubated at room temperature
for 1 h with HRP-conjugated secondary antibodies (anti-mouse IgG or
anti-mouse IgM; BioRad, U.K.), followed by six washes in TBS-T before
visualisation with ECL (Amersham, U.K.). Membranes were imaged
using the UVP transilluminator (UVP BioDoc-IT™ System, U.K.).
2.4. Immunohistochemistry
Paraffin blocks were kept at room temperature and 5 μm serial
tissue sections cut and placed on SuperFrost∗/Plus microscope slides
(Manzel Gläser, U.S.A.) and stored at room temperature until used.
Immunohistochemistry was performed as previously described (Lange
et al., 2004), with slight modifications. The primary antibodies used
were anti-CRP-I and CRP-I (1/100; monospecific polyclonal mouse) and
Fig. 1. Molecular scheme of post-translational
protein deimination. Peptidylarginine deiminase
(PAD) causes deimination/citrullination of arginine
in a calcium-dependent manner. Deimination/ci-
trullination is the catalysis of peptidyl arginine to
peptidyl citrulline residues, using oxygen from water
and releasing nitrogen as ammonia.
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F95 (1/100; monoclonal mouse-IgM); for detection of CRP forms and
deiminated proteins respectively. Sections immunostained with CRP-I
and CRP-II antibodies were visualised with fast red solution and back-
ground stained with 1% methylene blue, while tissue sections im-
munostained with F95 were visualised with diaminobenzidine/hy-
drogen peroxide (DAB) and background stained with haematoxylin
blue. As a negative control, normal mouse ascitic fluid was used, which
contained IgG1, IgG2a, IgG2b, and IgG3 as verified with the ISOStrip
Mouse Monoclonal Antibody Isotyping Kit, following the manufac-
turer's instructions (Boehringer Mannheim, Germany). Four larvae were
analysed for each developmental stage.
3. Results
3.1. Phylogenetic comparison of pentraxin (CRP and SAP) protein
sequences, arginine sites and disordered regions
Phylogenetic analysis showed that both cod CRP forms grouped
closer with human CRP than human SAP, while cod CRP-I grouped
closest with SAP-like pentraxins from rainbow trout (Oncorhynchus
mykiss) and Arctic char (Salvelinus alpinus) and cod CRP-II grouped most
closely with carp (Cyprinus carpio carpio), goldfish (Carassius auratus)
and zebrafish (Danio rerio) CRP-like pentraxins (Supplementary
Fig. 3A). The two cod CRP forms differed in number of disordered re-
gions as CRP-II had one while CRP-I contained none as assessed by
FoldIndex© (Supplementary Fig. 3B). Based on multiple sequence
alignment of the whole amino acid sequences (using Clustal Omega),
cod CRP-I and CRP-II showed close identity to both human CRP and
SAP, while the two cod CRP forms differed in number of arginine re-
sidues, with CRP-I containing 8 arginines (at sites 53, 60, 86, 128, 133,
158, 187, 228) and CRP-II containing 11 arginines (29, 38, 46, 48, 57,
62, 96, 104, 113, 116, 118). Notably only 4 of these arginines occupied
the same amino acid location (Supplementary Fig. 3C). Some of the cod
arginine residues are conserved between the two CRP forms, zebrafish
and human (Supplementary Fig. 3C).
3.2. Western blotting of deiminated forms of CRP-I and CRP-II and proteins
in mucus and serum
Immunoprecipitated CRP-I and CRP-II proteins from cod serum and
mucus, as well as crude cod serum and mucus protein isolates, were
analysed by Western blotting for presence of CRP-I, CRP-II and post-
translational deimination (Fig. 2). All protein samples were heated to
100 °C in 2 × Laemmli buffer containing 5% β-mercaptoethanol before
separation by SDS-PAGE. In crude mucus and serum extracts both CRP-I
and CRP-II showed differing banding patterns. CRP-I was strongly de-
tected in mucus with two prominent bands in the 37 and 45 kDa re-
gions, one band around 75 kDa and another band at 100 kDa, while in
serum, the 37 kDa band was hardly detectable, the 45 kDa band was
present as well as the 75 and 100 kDa band, but an additional promi-
nent band at 50 kDa was observed in serum, that was not present in the
mucus sample (Fig. 2A). For CRP-II, in mucus some prominent bands
were seen at 50 kDa and just below 75 kDa, and these were also de-
tected in serum, while in serum an additional thick band (possibly re-
presenting a few bands close together) was prominent just below
50 kDa (Fig. 2B). Both CRP-I and CRP-II immunoprecipitated proteins
showed signs of post-translationally deiminated forms as detected by
the pan-deimination F95 antibody, which detects deiminated proteins
by binding to protein citrulline (Fig. 2A and B (F95)). Deimination
positive bands differed somewhat between mucus and serum. For CRP-I
two single deiminated bands were observed in mucus at 50 and 75 kDa
respectively, while in serum the 50 kDa band was much broader, in-
dicating the presence of several F95 positive bands in close proximity in
this region. These deimination positive bands corresponded with CRP-I
positive bands detected in whole serum and mucus protein extract at
75 kDa and in the 50 kDa range in serum, while CRP-I positive bands in
mucus were around 37 and 45 kDa. As deimination changes protein
conformation (Vossenaar et al., 2003; Witalison et al., 2015a) it may
possibly have affected the migration observed here of deiminated CRP
compared to non-deiminated forms in SDS-PAGE. For CRP-II a similar
difference in deiminated binding pattern was observed between mucus
and serum with two deiminated bands at 50 and 75 kDa in mucus, al-
beit the 50 kDa band was fainter, while in serum, the deiminated band
in the 50 kDa region was very strong, indicating also the presence of
several deiminated bands in this size range. The deimination positive
bands detected around 50 kDa correlated with the narrow CRP-II po-
sitive bands detected at 50 kDa in both mucus and serum, and the
further strong CRP-II positive bands detected just below 50 kDa in
serum, while the 75 kDa deimination positive band migrated higher
compared to the CRP-II band detected just below 75 kDa, both in serum
and mucus. Thus there seemed some difference in migration of putative
deiminated CRP subunits in this size range. The presence of deiminated
total proteins in crude mucus and serum protein extract, using the pan-
deimination F95 antibody, revealed considerably higher levels of total
deiminated proteins in serum compared to mucus (Fig. 2C).
3.3. Histological analysis of CRP-I, CRP-II and deiminated proteins in cod
ontogeny
3.3.1. CRP-I and CRP-II in hepatic tissue in cod larvae ontogeny 3–84 days
post hatching
The main detection site for both CRP forms was the liver, where
they were clearly detected in hepatocytes from 7 d.p.h. onwards. A
temporal difference in hepatic detection of the two forms was observed
(Fig. 3). While CRP-I detection diminished at 50 d.p.h. and was hardly
visible at 84 d.p.h., CRP-II remained strongly detectable at 50 d.p.h. and
slightly reduced, but still clearly present, at 84 d.p.h. CRP-I showed a
stronger specificity for brain and eye while CRP-II showed a stronger
mucosal association, particularly in gut and skin. This difference was
particularly prominent at 35 d.p.h. (Fig. 3; Table 1). The temporal and
spatial pattern of protein detection for CRP-I and CRP-II was consistent
in all 4 fish analysed for each developmental stage.
3.3.2. Detection of CRP-I in cod larvae 3–84 days post hatching – hepatic
and extrahepatic detection
CRP-I specific immunodetection in nervous tissue is highlighted in
Fig. 4a, also showing deiminated proteins in corresponding regions.
During ontogeny CRP-I was detected as following: at 3–7 d.p.h. a faint
response was seen for CRP-I in the plexiform layers of eye and a faint
detection in liver. At 11 d.p.h. a strong response was seen in the liver as
well as in the inner and outer plexiform layers and in rods and cones
(photoreceptor layer) of the eyes. By 14 d.p.h. CRP-I was detected in the
axons and photoreceptors of the eyes and positive signal was increased
in the liver. On day 17 some response was also detected in the cell
fibrils of the brain and increased on day 21, where a reaction was also
seen in the liver and in pancreas (Fig. 5A). At 28 d.p.h. and 35 d.p.h. the
detection in the liver was strong. At 35 d.p.h. very strong reaction was
seen in cell fibrils of brain (Fig. 4a-i), in the inner plexiform layer and
inner nuclear layer of the eyes (Fig. 4a–ii), and in the spinal cord
(Fig. 5B). Some positive response was seen in myofibrils of skeletal
muscle (Fig. 5C). Some faint positive detection was seen in the brush
border in wall of the intestines at 17–50 d.p.h. By day 50 a strong re-
action was seen in the liver, in chondrocytes (Fig. 5D) and the head
kidney was positive while at 84 d.p.h. only the liver showed a faint
positive reaction. Some unspecific staining, mainly defined to the brush
border, was seen in the intestines on day 84 (Table 1). The character-
istic tissue distribution identified for the two CRP forms as described
above was consistent in all 4 cod larvae tested for each developmental
stage.
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3.3.3. Detection of CRP-II in cod larvae 3–84 days post hatching – hepatic
and extrahepatic detection
CRP-II specific immunodetection in mucosal tissue is highlighted in
Fig. 4b, also showing deiminated proteins in corresponding regions. At
3–7 d.p.h. some positive detection for CRP-II was seen in the liver, the
intestines and in photoreceptors of the eyes at 7 d.p.h. At 11 d.p.h. a
relatively weak response was seen in the inner and outer plexiform
layer of the eyes, a reaction was also seen in the liver and a sporadic
response in the brain. By day 14 the liver detection was strong and the
sacciform cells of skin showed a positive reaction as well as axons and
photoreceptors of the eyes. At 17 d.p.h. some response was seen in the
inner and outer plexiform layers of the eyes, albeit not as strong a re-
action as seen with the anti-CRP-I antibody. At 21 d.p.h. the liver de-
tection had become very strong and positive reaction was also seen in
the pancreas (Fig. 5E). At 28 d.p.h. a strong reaction in the liver was
maintained and reaction was also seen in the small intestines and the
skin as well as in chondrocytes (Fig. 5H). On day 35 the liver detection
was very strong (Figs. 3 and 4B) and a strong reaction was seen in
intestines, particularly in goblet-like cells of the small intestines
(Fig. 4b-i), as well as in sacciform cells of epidermis and mucus
(Fig. 4b–ii and Fig. 5G). Chondrocytes also showed strongly im-
munopositive. On day 35, neither the eyes nor the brain showed any
reaction (Fig. 4b). At 84 d.p.h. the liver showed a strong positive de-
tection, as well as fibrous layer in notochord (Fig. 5F), while no positive
staining showed in brain or eyes (Table 1).
3.3.4. Detection of deiminated proteins in in cod larvae
Deiminated proteins, as identified by the pan-deimination antibody
(F95) were detected in corresponding sites to CRP-I and CRP-II in cod
ontogeny, namely in brain (Fig. 4c), eye (Fig. 4d), gut (Fig. 4e), liver
(Fig. 4f), pancreas (Fig. 5I), spinal cord and notochord (Fig. 5J), muscle
and sacciform cells in epidermis (Fig. 5K), chondrocytes of gills
(Fig. 5L) and kidney (not shown).
4. Discussion
For the first time, deiminated forms of CRP and SAP-like pentraxins
have been identified and are shown in cod serum and mucus. Both cod
CRP forms differ in number of arginine residues, which are putative
candidates for post-translational deimination, some of which are
Fig. 2. Western blotting showing CRP-I and CRP-II and deiminated CRP forms in cod mucosa and serum. A) CRP-I was immunoprecipitated from adult cod
mucus and serum using the mono-specific mouse anti-cod CRP-I antibody. Eluted CRP protein samples were heated to 100 °C in 2 × Laemmli buffer containing 5% β-
mercaptoethanol before separation by SDS-PAGE using 4–20% Mini-Protean TGX protein gels. CRP-I elutes were thereafter analysed for post-translational protein
deimination using the monoclonal mouse IgM pan-deimination F95 antibody, which detects protein citrulline (Nicholas and Whitaker, 2002), for detection of
putative deiminated forms of CRP-I. Deimination positive bands (F95) were seen at 75 and 50 kDa in mucus, while in serum a deimination positive band was also at
75 kDa but in the 50 kDa range several bands were F95 immunopositive. These deimination positive bands correspond with CRP-I positive bands detected in whole
serum and mucus protein extract at 75 kDa and in the 50 kDa range in serum, while CRP-I bands in mucus were around 37 and 45 kDa. As deimination changes
protein conformation it may possibly affect migration of deiminated CRP compared to non-deiminated forms in SDS-PAGE. Also, a difference in CRP subunit patterns
was observed between mucus and serum while CRP-I positive bands were detected in mucus and serum at 100, 75, and 45 kDa; a 50 kDa band was strongly expressed
in serum, but not in mucus, which had a 37 kDa band that was stronger expressed compared to serum. All protein samples were heated to 100 °C in 2 × Laemmli
buffer containing 5% β-mercaptoethanol before separation by SDS-PAGE. B) CRP-II was immunoprecipitated from adult cod mucus and serum using a mono-specific
mouse anti-cod CRP-II antibody. Eluted samples were heated to 100 °C in 2 × Laemmli buffer containing 5% β-mercaptoethanol before separation by SDS-PAGE
using 4–20% Mini-Protean TGX protein gels. CRP-II protein elutes were blotted against the pan-deimination antibody F95, for detection of putative post-transla-
tionally deiminated forms of CRP-II. Deimination positive bands were detected at 50 and 75 kDa in mucus, while in serum several bands in the 50 kDa region were
strongly detected as well as a 75 kDa band. The deimination positive bands detected around 50 kDa correlate with the narrow CRP-II positive bands detected at
50 kDa in both mucus and serum, and the further strong CRP-II positive bands detected just below 50 kDa in serum, while the 75 kDa deimination positive band
migrates higher compared to the CRP-II band detected just below 75 kDa, both in serum and mucus. Thus there seems some difference in migration of putative
deiminated CRP subunits in this size range. C) Total deiminated proteins, as detected by the pan-deimination F95 antibody, are detected at lower levels in mucus
compared to serum, while protein load, as assessed by Ponceau red staining, indicates even protein load. Protein standard (std) is indicated in all blots and the
corresponding PonceauS (PoncS) staining is shown as a loading control beneath each Western blot. (For interpretation of the references to colour in this figure legend,
the reader is referred to the Web version of this article.)
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conserved between the two isoforms and also throughout phylogeny
(Supplementary Fig. 3C). Disordered regions, which are the most prone
structures for undergoing post-translational protein deimination, are
revealed here in a variety of pentraxins throughout phylogeny, in-
cluding in cod CRP-II (Supplementary Fig. 3B). Phylogenetic analysis,
based on amino acid sequence alignment, showed that both cod CRPs
grouped closer to human CRP than SAP, while CRP-I grouped more
with some teleost SAP-like pentraxins and CRP-II grouped closer with
some teleost CRP-like pentraxins. This correlates with previous findings
where, albeit both forms were classified as CRP pentraxins based on
binding specificity, N-terminal sequence analysis of cod CRP-I showed
closer similarity to SAP while cod CRP-II was closer to CRP (Gisladottir
et al., 2009). This trend was further reflected in the im-
munohistochemical detection during cod ontogeny, revealing some
distinctive differences in tissue localisation of the two forms. CRP-I
dominated in brain, spinal cord, eye and kidney, while CRP-II was
significantly more prominent in mucosal tissues of skin and gut. Both
temporal and spatial differences were observed between the two forms
in the various tissues. CRP-I showed considerably higher detection in
parts of the nervous system i.e. white matter of brain, and inner and
outer plexiform layers and photoreceptors of the eye from 5 d.p.h. on-
wards, peaking at 35 d.p.h., while only very faint levels of CRP-II were
detected in the photoreceptor layer of the eye between 7 and 14 d.p.h.
which were thereafter was not detected at older stages. A particularly
striking difference was observed between the two CRP forms in nervous
tissue of brain, spinal cord and eye at 35 d.p.h., where a very strong
positive response was seen for CRP-I, while CRP-II showed no positive
reaction (Figs. 4 and 5). CRP-I was also detected in head kidney, which
did not show positive for CRP-II in these samples. A prominent strong
mucosal association for CRP-II was evident in mucosal tissues of in-
testines and skin, showing positive in goblet cells and sacciform cells
(Fig. 4b). Both forms showed strong hepatic detection, indicating the
liver to be the main production site of both CRP types, albeit CRP-II
appeared sooner and showed a stronger reaction at the older stages
tested (50 and 84 d.p.h.; Fig. 3). These findings are consistent with that
the liver is the main production site of CRP and SAP (Hutchinson et al.,
1994), while extrahepatic pentraxin detection has previously been de-
scribed (Murphy et al., 1991), including in muscle (Rees et al., 1988),
smooth muscle cells in atherosclerotic plaques (Yasojima et al., 2001),
kidney (Jabs et al., 2003), respiratory tract (Gould and Weiser, 2001),
lung epithelia (Dong and Wright, 1996; Ramage et al., 2004), cervical
mucus (Raffi et al., 1977) and in brain (Yasojima et al., 2000; Mulder
et al., 2010). The strong nervous tissue detection of Cod CRP-I shows
thus a more similar tissue localisation to human SAP, which for ex-
ample binds to fibrillary deposits in dementia brains (Rostagno et al.,
2007) and to amyloid plaques in Alzheimer's disease brains, where it is
also associated with wound repair (Mulder et al., 2010). SAP is also
associated to other amyloidosis, as well as liver and renal fibrosis where
SAP inhibits proteolytic cleavage and stabilises fibril aggregates (Xi
et al., 2015). As a pattern recognition receptor, SAP removes opsonised
Fig. 3. Immunohistological analysis of hepatic CRP-I and CRP-II in cod ontogeny. Representative histological figures of CRP-I and CRP-II protein detection in
liver are shown in cod ontogeny at 11, 21, 35, 50 and 84 d.p.h. Both forms are detected in hepatocytes at all stages examined. While the levels of CRP-I and CRP-II
were similar at 11 d.p.h.; CRP-I detection was relatively stronger in liver hepatocytes at 21 d.p.h. than CRP-II, but thereafter CRP-I levels reduced on day 50 and CRP-I
immune-detection was very low in hepatocytes at 84 d.p.h. Protein-levels of CRP-II was lower at 21 d.p.h. compared to CRP-I, but similar to CRP-I at 35 d.p.h.;
thereafter CRP-II protein detection was visible stronger in hepatocytes at both 50 and 84 d.p.h. All figures are photographed using a 40× objective and scale bars
represent 50 μm in all figures.
Table 1
CRP-I and CRP-II in organs and tissues during early cod ontogeny. A
schematic overview of immunohistochemical detection of CRP-I and CRP-II in
various organs of cod larvae from 3 to 84 days post hatching (d.p.h.).
Organ CRP-I CRP-II
Detection at days post
hatching:







Spinal cord 35 negative
Notochord negative 84
Intestines 17–50
(faint and restricted to brush
border)
11–50





(low at all stages)
7–84
(prominent at all stages)
Chondrocytes of gills 28–84 28–84
Muscle 21–35 7–84
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Fig. 4. Histological immunostaining of
CRP-I and CRP-II. a) CRP-I in brain and
eye. Immunohistochemical detection of
CRP-I in the brain and eye at 35 d.p.h.: CRPI
was clearly seen in the brain in cell fibrils of
the medulla oblongata (a–i); The forebrain
and optic tectum fibrils were also positive.
CRPI was also strongly expressed in the eye
(a-ii): the internal plexiform layer (ipl),
consisting of the dense reticulum of fibrils of
retinal ganglion cells and cells of the inner
nuclear (in) layer are strongly positive. b)
CRP-II in mucosal tissues. A strong detec-
tion was seen in liver and intestines at
35 d.p.h. while brain and eye were negative.
b-i) A distinctively strong detection was
observed in goblet cells of the intestines; b-
ii) Strong positive was seen in mucosal layer
and sacciform cells (arrows) of epidermis. c-
d) Deiminated proteins (F95) were de-
tected in corresponding sites to CRP-I and
CRP-II using the pan-deimination F95 anti-
body in: c) medulla oblongata of brain; d)
eye; e) mucosal layer of gut and epidermis
(arrows); f) liver; note positive hepatocytes.
Scale bars represent 100 μm (a; b) and
50 μm (a-i; a-ii; b-I; b-ii; c-f).
Fig. 5. Examples showing CRP-I and CRP-II extrahepatic immunopositive detection, as well as deiminated proteins at different developmental stages. A-D) CRP-I in:
A) Pancreas, strong positive in Island of Langerhans at 21 d.p.h.; B) Spinal cord at 35 d.p.h., note positive in neuronal tissue of spinal cord (sp) while notochord (nc) is
negative; C) Muscle at 21 d.p.h., positive in striated myofibril in muscle cells and fibroblasts covering muscle cells; D) Chondrocytes of gill arches at 28 d.p.h.; E-H)
CRP-II in: E) Pancreas at 21 d.p.h., strong positive in Island of Langerhans; F) CRP-II in fibrous layer of notochord (arrows) is positive at 84 d.p.h – note negative in
spinal cord for CRP-II.; G) Sacciform cells are strongly positive in mucosal epidermis at 50 d.p.h.; H) Chondrocytes of gill arches at 28 d.p.h., note also strong positive
in mucosal epidermis; I-L) Deiminated proteins (F95) in: I) Island of Langerhans in pancreas at 57 d.p.h.; J) Spinal cord is positive (sp) and peripheral and fibrous
layer (arrow) of notochord (nc) at 28 d.p.h.; K) Muscle fibres, epidermis and sacciform cells (arrow) of skin at 28 d.p.h.; L) Chondrocytes of gills at 28 d.p.h.; . All scale
bars represent 50 μm.
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and apoptotic cells (Ma et al., 2011) and is thus an important factor in
tissue remodelling after tissue damage. Structural conformation of SAP,
for example via post-translational deimination, may play roles in its
function and this is also interesting in relation to findings on horseshoe
crab SAP-like pentraxin, which contains four disordered regions
(Supplementary Fig. 3B) and has been shown to have two molecular
aggregations with different calcium binding sites; while sequence
homology with human SAP is low, the structural homology is high and
binding specific preferences similar (Shrive et al., 2009).
The deimination and mucosal detection of both cod CRP forms is of
considerable interest as teleost skin mucosa is representative of human
mucosal surfaces I of respiratory tract, gut and uterus (Gomez et al.,
2013). In several fish species, either a single pentraxin type or both
short types (CRP and SAP), have been isolated and characterised in
serum (White et al., 1981; Szalai et al., 1994; Jensen et al., 1995, 1997;
Lund and Olafsen, 1998; Kovacevic et al., 2015; Lee et al., 2017; Shi
et al., 2018), while pentraxins have also been shown to form part of the
humoral defence in mucosa of some fish (Yano, 1996; Jones, 2001).
Mucosal pentraxins have for example been described in skin mucosa in
the common skate (Raja kenojei) (Tsutsui et al., 2009), lumpsucker
(Cyclopterus lumpus) (Patel and Brinchmann, 2017) and Atlantic salmon
(Salmo salar) (Valdenegro-Vega et al., 2014). In zebrafish (Danio rerio),
a multigene family of CRP-like proteins has been identified and struc-
tural conformations studied, albeit not post-translationally modified
forms, while mucosal forms were not described (Chen et al., 2011,
2015; Falco et al., 2012; Bello-Perez et al., 2017a). Some studies on
pentraxin involvement in the acute phase response of fish have been
carried out. For example, turpentine injection resulted in an eighteen
fold increase serum level of CRP in channel catfish (Ictalurus punctatus)
(Szalai et al., 1994) while reduced serum levels of CRP were seen in
rainbow trout (Oncorhynchus mykiss) and both CRP and SAP levels were
reduced in plaice (Pleuronectes platessa L.) (White et al., 1981). The
change in the gene expression of pentraxins during acute phase re-
sponse has also been studied in some fish species following infection,
inflammation or stress induction with varying results (Cairns et al.,
2008; Talbot et al., 2009; Kovacevic et al., 2015; Bello-Perez et al.,
2017b; Shi et al., 2018). In previous studies on the two cod CRP forms,
infection or acute phase induction appeared to have non-significant
effect on the serum levels of CRP-I or II (Magnadottir et al., 2010,
2011), while increased gene expression of both pentraxins was ob-
served in anterior kidney, inducing cortisol release and cytokine (IL-1β)
stimulation (Audunsdottir et al., 2012). In granulatomous disease in
cod, CRP-II was detected at stronger protein level than CRP-I and thus
seems to be the more immune-related form in cod (Magnadottir et al.,
2013; Gudmundsdottir et al., 2014). CRP has been identified at the
protein level in gill and skin mucus of Atlantic salmon (Salmo salar)
affected by amoebic gill disease (Valdenegro-Vega et al., 2014) and in
trematode infection of English sole (Parophrys vetulus) (Moore et al.,
1994), while goldfish (Carassius auratus) CRP was shown to enhance
complement-mediated lysis of tryptanosomes in vitro (Kovacevic et al.,
2015), and ayu (Plecoglossus altivelis) CRP/SAP has been shown to ag-
glutinate bacteria and to inhibit complement-mediated opsonophago-
cytosis (Shi et al., 2018). However, changes in post-translational
modifications have hitherto received little attention, besides a recent
study identifying significant increase in total deiminated proteins and
deiminated histone H3 in gut-associated mucosal tissue of LPS im-
munostimulated cod larvae (Magnadottir et al., 2018). The role of such
post-translational modifications, besides increased CRP protein levels
per se, may be of pivotal importance for protein function, protein-pro-
tein interactions and protein moonlighting, an evolutionary acquired
phenomenon allowing proteins to exhibit multifunctional physiological
or biophysical functions within one polypeptide chain (Henderson and
Martin, 2014; Jeffrey, 2018). This may further expand the repertoire of
immune recognition and may modify the binding specificity and pat-
tern recognition properties of both CRP forms, depending on environ-
ment and tissue localisation. Heterogeneity in the two cod CRP forms
has previously been shown with respect to glycolysation (Gisladottir
et al., 2009) and in Indian carp (Labeo rohita) heterogeneity of glyco-
sylated pentraxin subunits has been shown depending on environment
(Mandal et al., 1999), while other post-translational modifications, such
as deimination revealed here, remain to be investigated in further detail
and may be of considerable importance.
The detection of deimination positive CRP forms found in the pre-
sent study is maybe not surprising when considering the presence of
arginines in both CRP-I and CRP-II (Supplementary Fig. 3C). The ar-
ginines present in both CRP forms are putative candidates for post-
translational deimination by irreversible conversion into citrulline, in a
calcium dependent manner by peptidylarginine deiminases (PADs), and
may result in changed protein structure and function (Vossenaar et al.,
2003; György et al., 2006) of CRP. This may also explain in part the
slightly different migration observed for deimination positive (F95)
CRP bands, when compared to CRP-I and II detection in crude mucus
and serum protein preparations. The banding pattern for deiminated
CRP-I and CRP-II positive bands varied somewhat between mucus and
serum, possibly reflecting differently post-translationally deiminated
forms of CRP present depending on tissue type. In addition, CRP may
also be complexed with or bound to deiminated neo-epitopes of other
proteins, including histones; possibly representing some of the deimi-
nation positive bands detected at lower levels. As pattern-recognition
molecules, pentraxins form part of the tissue remodelling machinery,
via DAMPS and clearance of apoptotic cells, and can also contribute to
clearance and processing of nuclear antigens. This may be of particular
importance in tissues with ongoing neurogenesis such as the brain and
eye and the presence of deiminated histone H3 and deiminated proteins
was recently described in these tissues throughout early cod ontogeny
(Magnadottir et al., 2018).
As PADs are conserved throughout phylogeny from bacteria to
mammals, arginine deiminases of commensals, pathogenic bacteria and
parasites may contribute to deiminated protein generation in the host.
Arginine deiminases have indeed been identified in various pathogens
of cod such as Vibrio anguillarum (YP_004567339.1), Aeromonas sal-
monicida (YP_001140162.1) and Photobacterium damselae
(VDA_002926). In human oral mucosa, Porphyromonas gingivalis has
been shown to contribute to deiminated auto-antigens and associated
autoimmune pathologies (Rosenstein et al., 2004; Stobernack et al.,
2016; Potempa et al., 2017). While commensals might modulate CRP
via changes in deimination for regulation of tissue remodelling and
homeostasis, pathogens may possibly also use their arginine deiminase
activity as a mechanism to aid immune evasion by modifying CRP via
deimination-mediated structural changes and manipulate CRP-medi-
ated inflammatory responses.
Protein deimination is involved in an array of human pathologies,
including autoimmune diseases and cancer (Witalison et al., 2015a,
2015b; Crevecoeur et al., 2017), where CRP has also been implicated
either through raised levels, or other hitherto unexplained pathways
(Ansar and Ghosh, 2013). While pentraxins are known glycoproteins,
post-translational deimination has not been studied in CRP before and it
may well be possible that CRP is structurally modified via deimination
in these diseases, exposing deiminated neo-epitopes which contribute to
inflammatory responses. In addition, CRP is known to bind to damage
associated molecular patterns (DAMPS), some of which may contain
deiminated neo-epitopes, leading to C1q binding and activation of the
complement system. Indeed, the presence of pentraxins and circulating
deiminated autoantibodies correlates in various autoimmune and in-
flammatory diseases as well as fibrosis (Gitlin et al., 1977; Robey et al.,
1984; Breathnach et al., 1989; Du Clos, 1996; Butler et al., 1999; Li
et al., 2010; Acharya et al., 2012 . Martinoid et al., 2016). Tissue de-
posited CRP is thought to be structurally different from circulating
pentameric CRP (Eisenhardt et al., 2009; Thiele et al., 2014; Braig et al.,
2017) and such conformational change of CRP is associated with
proinflammatory properties (Braig et al., 2014; Strang et al., 2012).
Monomeric forms of CRP are increasingly being linked to various
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diseases (Thiele et al., 2015) and are for example indicated to be a key
driver of Alzheimer's disease development (Slevin et al., 2015). Inter-
estingly, circulating pentameric CRP localised to damaged tissue has
recently been shown to bind to cell-derived microvesicles, introducing
structural changes in CRP, with the CRP-microvesicle complexes en-
hancing leukocyte recruitment (Braig et al., 2017). Importantly, protein
deimination has been shown to be crucial for cellular microvesicle re-
lease (Kholia et al., 2015; Kosgodage et al., 2017). As these are calcium-
mediated pathways, the regulatory role of PAD-mediated microvesicle
release on CRP function in different tissues and pathologies may be of
great interest. The newly identified deimination of CRP here, reveals a
putatively novel mechanism that may affect structural changes in CRP
and thus be of great relevance for understanding CRP function in var-
ious pathologies. This may also offer novel ways of modulating CRP-
mediated inflammation using inhibitors of deimination. Indeed, phar-
macological PAD inhibitors have been shown to be effective in neu-
roinflammatory (Lange et al., 2011, 2014) and autoimmune animal
models (Chumanevich et al., 2011; Witalison et al., 2015b; Willis et al.,
2011); as well as having anti-cancer effects through modulation of
microvesiculation (Kholia et al., 2015; Kosgodage et al., 2017). Due to
the phylogenetic conservation of pentraxins, the findings presented
here in teleost cod may bring novel insights into CRP and SAP function
in various human pathologies. In the light of established and newly
developed PAD inhibitors (Bicker and Thompson, 2013; Mondal et al.,
2018), the attuning of CRP and SAP deimination may offer novel
therapeutic approaches in pathologies where PAD activation and pen-
traxin function may be intertwined.
5. Conclusion
This is the first ontogeny study on pentraxin forms CRP-I and CRP-II
in early cod development, revealing tissue specificity for nervous versus
mucosal tissue for the two different forms, reflecting tissue localisation
of human SAP and CRP respectively. For the first time deiminated forms
of pentraxins are described. CRP-I and CRP-II were found to differ in
deimination in mucus and serum, indicating protein moonlighting
through this post-translational modification in different tissue types.
This study provides novel insights into tissue specific localisation and
putative novel effects on structural changes of pentraxins, mediated
through post-translational protein deimination. Our findings may fur-
ther current understanding of CRP and SAP function in homeostasis and
disease.
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